Medacta Announces 2025 AGM Details and Key Proposals

An announcement from Medacta Group SA ( (CH:MOVE) ) is now available.

Medacta Group SA has announced the details of its 2025 Annual General Meeting, scheduled for May 7, 2025, in Rancate, Switzerland. Shareholders can attend in person or vote via proxy, and are invited to submit questions to the Board of Directors. Key proposals include a dividend distribution of CHF 13.7 million, the re-election of Dr. Alberto Siccardi as Chairman, and the re-election of board members and the Remuneration Committee. The meeting will also address the approval of compensations for the Board and Executive Management, and the re-election of the Independent Proxy Holder and Auditors.

More about Medacta Group SA

Medacta is a global leader specializing in innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Founded in 1999 in Switzerland, the company is dedicated to enhancing patient care and healthcare sustainability through collaboration with expert surgeons, continuous R&D investments, and cutting-edge technologies. Medacta emphasizes minimally invasive surgery and personalized patient solutions and supports medical education through the M.O.R.E. Institute. It operates in over 60 countries from its headquarters in Castel San Pietro, Switzerland.

YTD Price Performance: 8.80%

Technical Sentiment Signal: Strong Buy

Current Market Cap: $2.66B

For a thorough assessment of MOVE stock, go to TipRanks’ Stock Analysis page.